A Aralex Aachen research explorer

John W. Newman Sign in to save

OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

0

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (2)

18× University of California, Davis
18× Western Human Nutrition Research Center

Papers 18 stored

All · Aachen affiliation only

Additional file 1 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 7 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 6 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 6 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 3 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 8 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 5 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare other Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 5 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare other Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 7 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 2 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 1 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 3 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 2 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 4 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 4 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations
Additional file 8 of Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer’s disease—finding from Alzheimer’s Disease Neuroimaging Initiative
2026 Figshare article Medicine Alzheimer's disease research and treatments Open access

0

citations

18 results